• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用未标记探针检测子宫内膜癌中成纤维细胞生长因子受体2外显子7和12突变

Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.

作者信息

Liu Ting, Willmore-Payne Carlynn, Wallander Michelle L, Layfield Lester J

机构信息

Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.

出版信息

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):341-6. doi: 10.1097/PAI.0b013e318201dae8.

DOI:10.1097/PAI.0b013e318201dae8
PMID:21285871
Abstract

BACKGROUND

Endometrial adenocarcinomas are associated with a variety of molecular abnormalities including microsatellite instability, Kirsten rat sarcoma viral oncogene homolog mutations, and phosphatase and tensin homolog inactivation. Recently, mutations in fibroblast growth factor receptor 2 (FGFR2) have been described but their frequency and clinicopathologic characteristics are incompletely known.

METHODS

To determine the frequency of mutations in FGFR2 exons 7 and 12, 43 adenocarcinomas of the endometrium were studied by high-resolution melting analysis utilizing unlabeled probes and sequencing.

RESULTS

Three of 43 (7%) endometrial carcinomas harbored FGFR2 exon 7 mutations. All 3 mutations were S252W and occurred in endometrioid (type I) adenocarcinomas. Direct sequencing indicated that 2 of the S252W mutations were heterozygous, whereas 1 was presumably homozygous. No FGFR2 mutations were detected in exon 12.

CONCLUSIONS

FGFR2 mutations occur in approximately 7% of adenocarcinomas of the endometrium. Only carcinomas of an endometrioid morphology contain FGFR2 mutations, and in our series all were S252W. FGFR2 exons 7 and 12 unlabeled DNA probes allow for easy screening of endometrial carcinoma for the 2 most common FGFR2 mutations (S252W and N550K). Identification of these mutations may have important implications in directed molecular therapy.

摘要

背景

子宫内膜腺癌与多种分子异常有关,包括微卫星不稳定性、 Kirsten 大鼠肉瘤病毒癌基因同源物突变以及磷酸酶和张力蛋白同源物失活。最近,已报道成纤维细胞生长因子受体 2(FGFR2)突变,但其频率和临床病理特征尚不完全清楚。

方法

为了确定 FGFR2 外显子 7 和 12 中的突变频率,利用未标记探针和测序的高分辨率熔解分析研究了 43 例子宫内膜腺癌。

结果

43 例子宫内膜癌中有 3 例(7%)存在 FGFR2 外显子 7 突变。所有 3 个突变均为 S252W,且发生在子宫内膜样(I 型)腺癌中。直接测序表明,2 个 S252W 突变是杂合的,而 1 个可能是纯合的。外显子 12 未检测到 FGFR2 突变。

结论

FGFR2 突变约发生在 7%的子宫内膜腺癌中。只有子宫内膜样形态的癌含有 FGFR2 突变,在我们的系列研究中均为 S252W。FGFR2 外显子 7 和 12 的未标记 DNA 探针可轻松筛查子宫内膜癌中 2 种最常见的 FGFR2 突变(S252W 和 N550K)。识别这些突变可能对定向分子治疗具有重要意义。

相似文献

1
Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.使用未标记探针检测子宫内膜癌中成纤维细胞生长因子受体2外显子7和12突变
Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):341-6. doi: 10.1097/PAI.0b013e318201dae8.
2
FGFR2 alterations in endometrial carcinoma.子宫内膜癌中的 FGFR2 改变。
Mod Pathol. 2011 Nov;24(11):1500-10. doi: 10.1038/modpathol.2011.110. Epub 2011 Jul 1.
3
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.FGFR2突变与子宫内膜样子宫内膜癌的不良预后相关:一项NRG肿瘤学/妇科肿瘤学组的研究。
Gynecol Oncol. 2017 May;145(2):366-373. doi: 10.1016/j.ygyno.2017.02.031. Epub 2017 Mar 15.
4
FGFR2 mutations are rare across histologic subtypes of ovarian cancer.FGFR2 突变在卵巢癌的各种组织学亚型中都很少见。
Gynecol Oncol. 2010 Apr;117(1):125-9. doi: 10.1016/j.ygyno.2009.12.002. Epub 2010 Jan 27.
5
Rapid Identification of FGFR2 Gene Mutations in Taiwanese Patients With Endometrial Cancer Using High-resolution Melting Analysis.利用高分辨率熔解分析快速鉴定台湾子宫内膜癌患者的FGFR2基因突变
Appl Immunohistochem Mol Morphol. 2015 Aug;23(7):532-7. doi: 10.1097/PAI.0000000000000114.
6
Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.成纤维细胞生长因子受体抑制与紫杉醇和多柔比星在子宫内膜癌细胞中协同作用。
Int J Gynecol Cancer. 2012 Nov;22(9):1517-26. doi: 10.1097/IGC.0b013e31826f6806.
7
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.PIK3CA 错义突变与 3 级子宫内膜样癌的不良预后相关,但与浆液性子宫内膜癌无关。
Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19.
8
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.子宫内膜癌中频繁出现的FGFR2激活突变与颅缝早闭和骨骼发育异常综合征相关的种系突变相似。
Oncogene. 2007 Nov 1;26(50):7158-62. doi: 10.1038/sj.onc.1210529. Epub 2007 May 21.
9
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.尽管PTEN缺失,但抑制子宫内膜癌细胞中活化的成纤维细胞生长因子受体2会诱导细胞死亡。
Cancer Res. 2008 Sep 1;68(17):6902-7. doi: 10.1158/0008-5472.CAN-08-0770.
10
BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.子宫内膜样腺癌中BAX基因的体细胞移码突变:在微卫星不稳定的子宫内膜癌中肿瘤进展作用的证据
Lab Invest. 1998 Nov;78(11):1439-44.

引用本文的文献

1
Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome.综合征背景下的毛发上皮瘤:文献综述及1例Apert综合征病例报告
Dermatopathology (Basel). 2025 Aug 1;12(3):24. doi: 10.3390/dermatopathology12030024.
2
Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.在体外人子宫内膜基质细胞和小鼠子宫内膜中,巴多昔芬可降低子宫内膜癌相关的FGF18表达。
Endocrinology. 2016 Oct;157(10):3699-3708. doi: 10.1210/en.2016-1233. Epub 2016 Jun 6.
3
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers.
成纤维细胞生长因子受体(FGFRs)信号在人类癌症中的功能作用。
Apoptosis. 2013 Dec;18(12):1447-68. doi: 10.1007/s10495-013-0886-7.